SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MCorbley who wrote (438)8/18/1997 3:01:00 PM
From: MCorbley   of 1115
 
GERN vs. LDAKA: As an aside, one can't help wondering whether Wall Street has any grip on reality at all. Geron has reported a nice piece of scientific research, very pleasing intellectually but certainly not brilliant, and guaranteed to have absolutely no practical clinical value to anyone for a long, long time. As a result, Geron's stock price has practically tripled this month giving it a market capitalization of over $160 M. On the other hand, Lidak has provided at least a sketchy report of definitive results on a new therapy which could dramatically improve the quality of life of 50 million people in the U.S. alone by next year. For that, they have a falling stock price and a market cap around $90 M.

?????
M.C.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext